Advisory committee votes 17-4 to recommend FDA authorize Pfizer-BioNTech vaccine, opening door to rapid EUA
There were a million questions but little suspense.
For eight and a half hours, a panel of outside advisors debated Pfizer’s vaccine data, questioned endpoints …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
